1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Growing elderly population worldwide
5.2.2. Increasing incidence of plaque psoriasis and psoriasis arthritis
5.2.3. Favorable reimbursement policies for such therapeutics
5.3. Restraints
5.3.1. High cost of therapeutics
5.4. Opportunities
5.4.1. Rising prescription volume and approvals of biologic products
5.4.2. Emerging development of new biologics and novel pipeline drugs
5.5. Challenges
5.5.1. Probable health risks due to the medication

6. Psoriasis Therapeutics Market, by Molecule
6.1. Introduction
6.2. Biologics
6.3. Small Molecules

7. Psoriasis Therapeutics Market, by Route of Administration
7.1. Introduction
7.2. Oral
7.3. Parenteral
7.4. Topical

8. Psoriasis Therapeutics Market, by Dosage Forms
8.1. Introduction
8.2. Liquid
8.3. Semi-solid
8.4. Solid

9. Psoriasis Therapeutics Market, by Mechanism of Action
9.1. Introduction
9.2. IL blocker
9.3. PDE4 Inhibitors
9.4. TNF Inhibitors

10. Americas Psoriasis Therapeutics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Psoriasis Therapeutics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand

12. Europe, Middle East & Africa Psoriasis Therapeutics Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. AbbVie Inc.
14.2. Amgen, Inc.
14.3. Astellas Pharma Inc.
14.4. AstraZeneca plc
14.5. Bausch Health Companies Inc.
14.6. Biocon Limited
14.7. Boehringer Ingelheim International GmbH
14.8. Eli Lilly and Company
14.9. F. Hoffmann-La Roche AG
14.10. G & W Laboratories
14.11. GlaxoSmithKline plc
14.12. Johnson & Johnson services, inc
14.13. LEO Pharma A/S
14.14. mc2 therapeutics
14.15. Merck & Co., Inc.
14.16. Novartis AG
14.17. Pfizer Inc
14.18. Sun Pharmaceutical Industries Limited
14.19. Temisis Therapeutics
14.20. UCB S.A.

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, 2020 VS 2026 (USD BILLION)
FIGURE 2. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 3. GLOBAL PSORIASIS THERAPEUTICS MARKET: MARKET DYNAMICS
FIGURE 4. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY MOLECULE, 2020 VS 2026 (%)
FIGURE 5. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY MOLECULE, 2020 VS 2026 (USD BILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY MOLECULE, 2026
FIGURE 7. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2026 (USD BILLION)
FIGURE 8. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY BIOLOGICS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 9. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY SMALL MOLECULES, 2018-2026 (USD BILLION)
FIGURE 10. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 11. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2026 (%)
FIGURE 12. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2026 (USD BILLION)
FIGURE 13. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2026
FIGURE 14. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY ORAL, 2018-2026 (USD BILLION)
FIGURE 15. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 16. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2026 (USD BILLION)
FIGURE 17. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY PARENTERAL, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 18. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY TOPICAL, 2018-2026 (USD BILLION)
FIGURE 19. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY TOPICAL, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 20. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY DOSAGE FORMS, 2020 VS 2026 (%)
FIGURE 21. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY DOSAGE FORMS, 2020 VS 2026 (USD BILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY DOSAGE FORMS, 2026
FIGURE 23. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY LIQUID, 2018-2026 (USD BILLION)
FIGURE 24. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY LIQUID, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 25. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY SEMI-SOLID, 2018-2026 (USD BILLION)
FIGURE 26. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY SEMI-SOLID, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 27. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY SOLID, 2018-2026 (USD BILLION)
FIGURE 28. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY SOLID, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 29. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2020 VS 2026 (%)
FIGURE 30. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2020 VS 2026 (USD BILLION)
FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2026
FIGURE 32. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY IL BLOCKER, 2018-2026 (USD BILLION)
FIGURE 33. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY IL BLOCKER, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 34. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY PDE4 INHIBITORS, 2018-2026 (USD BILLION)
FIGURE 35. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY PDE4 INHIBITORS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 36. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY TNF INHIBITORS, 2018-2026 (USD BILLION)
FIGURE 37. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY TNF INHIBITORS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 38. AMERICAS PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 39. ARGENTINA PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 40. BRAZIL PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 41. CANADA PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 42. MEXICO PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 43. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 44. ASIA-PACIFIC PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 45. AUSTRALIA PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 46. CHINA PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 47. INDIA PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 48. INDONESIA PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 49. JAPAN PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 50. MALAYSIA PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 51. PHILIPPINES PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 52. SINGAPORE PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 53. SOUTH KOREA PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 54. TAIWAN PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 55. THAILAND PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 56. EUROPE, MIDDLE EAST & AFRICA PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 57. FRANCE PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 58. GERMANY PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 59. ITALY PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 60. NETHERLANDS PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 61. QATAR PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 62. RUSSIA PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 63. SAUDI ARABIA PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 64. SOUTH AFRICA PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 65. SPAIN PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 66. UNITED ARAB EMIRATES PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 67. UNITED KINGDOM PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 68. GLOBAL PSORIASIS THERAPEUTICS MARKET: FPNV POSITIONING MATRIX
FIGURE 69. GLOBAL PSORIASIS THERAPEUTICS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 70. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PSORIASIS THERAPEUTICS MARKET, BY TYPE

List of Tables

TABLE 1. GLOBAL PSORIASIS THERAPEUTICS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 4. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY MOLECULE, 2018-2026 (USD BILLION)
TABLE 5. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2026 (USD BILLION)
TABLE 6. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2026 (USD BILLION)
TABLE 7. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD BILLION)
TABLE 8. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2026 (USD BILLION)
TABLE 9. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2026 (USD BILLION)
TABLE 10. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2026 (USD BILLION)
TABLE 11. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY DOSAGE FORMS, 2018-2026 (USD BILLION)
TABLE 12. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY LIQUID, BY REGION, 2018-2026 (USD BILLION)
TABLE 13. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY SEMI-SOLID, BY REGION, 2018-2026 (USD BILLION)
TABLE 14. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY SOLID, BY REGION, 2018-2026 (USD BILLION)
TABLE 15. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2026 (USD BILLION)
TABLE 16. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY IL BLOCKER, BY REGION, 2018-2026 (USD BILLION)
TABLE 17. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY PDE4 INHIBITORS, BY REGION, 2018-2026 (USD BILLION)
TABLE 18. GLOBAL PSORIASIS THERAPEUTICS MARKET SIZE, BY TNF INHIBITORS, BY REGION, 2018-2026 (USD BILLION)
TABLE 19. AMERICAS PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 20. ARGENTINA PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 21. BRAZIL PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 22. CANADA PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 23. MEXICO PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 24. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 25. ASIA-PACIFIC PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 26. AUSTRALIA PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 27. CHINA PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 28. INDIA PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 29. INDONESIA PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 30. JAPAN PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 31. MALAYSIA PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 32. PHILIPPINES PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 33. SINGAPORE PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 34. SOUTH KOREA PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 35. TAIWAN PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 36. THAILAND PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 37. EUROPE, MIDDLE EAST & AFRICA PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 38. FRANCE PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 39. GERMANY PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 40. ITALY PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 41. NETHERLANDS PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 42. QATAR PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 43. RUSSIA PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 44. SAUDI ARABIA PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 45. SOUTH AFRICA PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 46. SPAIN PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 47. UNITED ARAB EMIRATES PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 48. UNITED KINGDOM PSORIASIS THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 49. GLOBAL PSORIASIS THERAPEUTICS MARKET: SCORES
TABLE 50. GLOBAL PSORIASIS THERAPEUTICS MARKET: BUSINESS STRATEGY
TABLE 51. GLOBAL PSORIASIS THERAPEUTICS MARKET: PRODUCT SATISFACTION
TABLE 52. GLOBAL PSORIASIS THERAPEUTICS MARKET: RANKING
TABLE 53. GLOBAL PSORIASIS THERAPEUTICS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 54. GLOBAL PSORIASIS THERAPEUTICS MARKET: MERGER & ACQUISITION
TABLE 55. GLOBAL PSORIASIS THERAPEUTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 56. GLOBAL PSORIASIS THERAPEUTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 57. GLOBAL PSORIASIS THERAPEUTICS MARKET: INVESTMENT & FUNDING
TABLE 58. GLOBAL PSORIASIS THERAPEUTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 59. GLOBAL PSORIASIS THERAPEUTICS MARKET: LICENSE & PRICING

Companies Mentioned

AbbVie Inc.
Amgen, Inc.
Astellas Pharma Inc.
AstraZeneca plc
Bausch Health Companies Inc.
Biocon Limited
Boehringer Ingelheim International GmbH
Eli Lilly and Company
F. Hoffmann-La Roche AG
G & W Laboratories
GlaxoSmithKline plc
Johnson & Johnson services, inc
LEO Pharma A/S
mc2 therapeutics
Merck & Co., Inc.
Novartis AG
Pfizer Inc
Sun Pharmaceutical Industries Limited
Temisis Therapeutics
UCB S.A.